BRKR vs BIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

BRKR

40.6
AI Score
VS
BIO Wins

BIO

51.0
AI Score

Investment Advisor Scores

BRKR

41score
Recommendation
HOLD

BIO

51score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BRKR BIO Winner
Revenue 1.66B 1.24B BRKR
Net Income -37.60M -155.70M BRKR
Gross Margin 47.9% 52.7% BIO
Net Margin -2.3% -12.5% BRKR
Operating Income -55.10M 106.70M BIO
ROE -1.6% -2.2% BRKR
ROA -0.6% -1.5% BRKR
Total Assets 6.05B 10.25B BIO
Cash 184.90M 517.00M BIO
Debt/Equity 0.76 0.17 BIO
Current Ratio 1.85 3.14 BIO
Free Cash Flow -59.20M 144.80M BIO

Relative Price Performance (Last 90 Days)

BRKR 1M: +7.7% · 3M: +3.6% BIO 1M: -5.3% · 3M: +24.7%

Current Technical Phase

BRKR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 57.2 · Price: $63.54

BIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.5 · Price: $367.91

Fundamentals Snapshot

Metric BRKR BIO
Market Cap — —
Forward P/E 25.9 35.9
Trailing P/E — 46.1
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.5% 0.5%
Operating Margin 0.1% 0.1%
EPS -0.75 8.20
Dividend Yield 0.00% —

Frequently Asked Questions

Based on our detailed analysis, BIO is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.